The 75th anniversary of the Tuohy corneal contact lens: A review.

Corneal contact lens History Rigid contact lens Sattler’s veil Scleral contact lens Tuohy

Journal

Contact lens & anterior eye : the journal of the British Contact Lens Association
ISSN: 1476-5411
Titre abrégé: Cont Lens Anterior Eye
Pays: England
ID NLM: 9712714

Informations de publication

Date de publication:
02 2023
Historique:
received: 06 07 2022
accepted: 08 09 2022
pubmed: 30 9 2022
medline: 18 1 2023
entrez: 29 9 2022
Statut: ppublish

Résumé

The aim of this review is to mark the 75th anniversary of the introduction of the original corneal contact lens of Tuohy in 1948. American documents in the public domain, such as census records and draft registration cards, were consulted in order to provide a more comprehensive biography of Kevin M Tuohy, inventor of the corneal contact lens, than those previously published. Perhaps due to a failure to consult original sources concerning the Tuohy corneal lens, some historical accounts have provided incomplete or incorrect information about its design and dimensions. The back surface specification of the bi-curve Tuohy lens in its standard diameter of 11.50 mm has been tabulated and edge lift and edge clearance values calculated. A colour photograph illustrates the fluorescein pattern of a Tuohy lens. Patients wearing Tuohy lenses were able to achieve a much longer wearing time compared to those wearing sealed scleral lenses since they eliminated corneal epithelial oedema, a frequent problem which necessitated removal of lenses after a few hours of wear due to cloudy vision. Only some of Tuohy lens wearers exhibited an adverse corneal response such as fluorescein staining after 12, or more, hours of wear. The clinical success of the Tuohy lens and the fact that its fitting procedure was simpler and quicker than that for scleral lenses encouraged optometrists to commence contact lens practice and to implement improvements in the design of the corneal lens.

Identifiants

pubmed: 36175319
pii: S1367-0484(22)00211-9
doi: 10.1016/j.clae.2022.101756
pii:
doi:

Substances chimiques

Fluorescein TPY09G7XIR

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101756

Informations de copyright

Crown Copyright © 2022. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Richard M Pearson (RM)

37 The Ridgeway, Tonbridge, Kent TN10 4NJ, United Kingdom. Electronic address: richardmpearson.email@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH